Priveq Investment is becoming a partner of Mediplast AB, a leader in consumables for healthcare. In 2009, Mediplast had sales of approximately SEK 310 m and has traced high growth through recent years. In tandem with Priveq’s investment, capital is…

-“In the midst of a tough exit market, we achieved our best exit ever and contributed to the creation of a new Swedish specialist pharmaceutical company with great international potential,” said Louise Nilsson, Partner and Investment Manager of Priveq Investment.

Priveq investment has as of today closed the exit transaction made on November 5th, 2009, thus sealing the outcome of the most successful exit, money multiple-wise, of our 27 years of history. The transaction was conditioned by a positive outcome…

As part of the Swedish Government sell-off of its former pharmacy monopoly, Priveq Investment and Investor Growth Capital are acquiring the pharmacies in clusters 6 and 7 offered by Apoteket Omstrukturering AB through newly incorporated entity Vårdapoteket i Norden AB.…

Priveq has entered an agreement to divest its holding in pharmaceuticals company Swedish Orphan International to Biovitrum today, creating Swedish Orphan Biovitrum AB.